These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 25851098)

  • 1. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment.
    Semenkovich K; Brown ME; Svrakic DM; Lustman PJ
    Drugs; 2015 Apr; 75(6):577-87. PubMed ID: 25851098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program.
    de Groot M; Marrero D; Mele L; Doyle T; Schwartz F; Mather KJ; Goldberg R; Price DW; Ma Y; Knowler WC;
    Psychosom Med; 2018; 80(2):167-173. PubMed ID: 29016549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achievement of glycemic control and antidepressant medication use in comorbid depression and type II diabetes.
    Brieler J; Salas J; Scherrer J
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 35947421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant medication use and glycaemic control in co-morbid type 2 diabetes and depression.
    Brieler JA; Lustman PJ; Scherrer JF; Salas J; Schneider FD
    Fam Pract; 2016 Feb; 33(1):30-6. PubMed ID: 26743722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis.
    Weitz ES; Hollon SD; Twisk J; van Straten A; Huibers MJ; David D; DeRubeis RJ; Dimidjian S; Dunlop BW; Cristea IA; Faramarzi M; Hegerl U; Jarrett RB; Kheirkhah F; Kennedy SH; Mergl R; Miranda J; Mohr DC; Rush AJ; Segal ZV; Siddique J; Simons AD; Vittengl JR; Cuijpers P
    JAMA Psychiatry; 2015 Nov; 72(11):1102-9. PubMed ID: 26397232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression, depression treatment, and insulin sensitivity in adults at risk for type 2 diabetes.
    Wagner J; Allen NA; Swalley LM; Melkus GD; Whittemore R
    Diabetes Res Clin Pract; 2009 Nov; 86(2):96-103. PubMed ID: 19720419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achievement of glycemic control and antidepressant medication use in comorbid depression and type 2 diabetes.
    Brieler JA; Salas J; Keegan-Garrett E; Scherrer JF
    J Affect Disord; 2023 Mar; 324():1-7. PubMed ID: 36566931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Depression, Antidepression Medications, and the Risk of Developing Type 2 Diabetes Mellitus: A Nationwide Population-Based Retrospective Cohort Study in Taiwan.
    Fang YJ; Wu TY; Lai JN; Lin CL; Tien N; Lim YP
    Biomed Res Int; 2021; 2021():8857230. PubMed ID: 33506043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive symptoms predict non-completion of a structured exercise intervention for people with Type 2 diabetes.
    Swardfager W; Yang P; Herrmann N; Lanctôt KL; Shah BR; Kiss A; Oh PI
    Diabet Med; 2016 Apr; 33(4):529-36. PubMed ID: 26220364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression-A Literature Review.
    Woo YS; Lim HK; Wang SM; Bahk WM
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32971941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetes Agents and Incident Depression: A Nationwide Population-Based Study.
    Kessing LV; Rytgaard HC; Ekstrøm CT; Knop FK; Berk M; Gerds TA
    Diabetes Care; 2020 Dec; 43(12):3050-3060. PubMed ID: 32978179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression in diabetic patients: the relationship between mood and glycemic control.
    Lustman PJ; Clouse RE
    J Diabetes Complications; 2005; 19(2):113-22. PubMed ID: 15745842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between depression and persistence with oral antihyperglycemic drugs in type 2 diabetes mellitus patients in Germany.
    Kostev K; Jacob L
    Psychiatry Res; 2018 Mar; 261():90-93. PubMed ID: 29291478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychotherapy of the child and adolescent with depression].
    McQuillan CT
    Bol Asoc Med P R; 2003; 95(3):21-8, 33-41. PubMed ID: 14584456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of depression among type 2 diabetes mellitus patients in India: A meta-analysis.
    Hussain S; Habib A; Singh A; Akhtar M; Najmi AK
    Psychiatry Res; 2018 Dec; 270():264-273. PubMed ID: 30273857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bidirectional association between depression and type 2 diabetes mellitus in women.
    Pan A; Lucas M; Sun Q; van Dam RM; Franco OH; Manson JE; Willett WC; Ascherio A; Hu FB
    Arch Intern Med; 2010 Nov; 170(21):1884-91. PubMed ID: 21098346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of binge eating disorder.
    Wilson GT
    Psychiatr Clin North Am; 2011 Dec; 34(4):773-83. PubMed ID: 22098803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population impact of depression either as a risk factor or consequence of type 2 diabetes in adults: a meta-analysis of longitudinal studies.
    Hasan SS; Clavarino AM; Mamun AA; Doi SA; Kairuz T
    Asian J Psychiatr; 2013 Dec; 6(6):460-72. PubMed ID: 24309855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sodium glucose cotransporter 2 inhibitors on weight in patients with type 2 diabetes mellitus.
    Barnett AH
    Postgrad Med; 2013 Sep; 125(5):92-100. PubMed ID: 24113667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.